Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.